Researchers Discover New Details About HIV-1 Entry and Infection

SEATTLE, February 15, 2007 /PRNewswire/ -- The primary targets of HIV-1 infection in the human vagina have been definitively identified in a new study published in the February 2007 issue of the journal Immunity, published by Cell Press. The findings are likely to guide development of new strategies that will prevent HIV-1 transmission.

"The majority of HIV-1 infected individuals worldwide are women who acquire HIV infection following sexual contact," said study authors Florian Hladik, M.D., Ph.D.; and M. Juliana McElrath, M.D., Ph. D, both of Fred Hutchinson Cancer Research Center. "Blocking HIV transmission and local spread in the female lower genital tract is key to prevent infection and ultimately to ease the pandemic."

Hladik and colleagues in the McElrath laboratory developed a unique model system to study the precise mechanisms by which HIV-1 enters the lower reproductive tract of human females. The researchers separated and removed the outer lining of vaginal cells, which serves as the first barrier to the virus. The isolated preparation of intact, viable, vaginal epithelium permitted examination of immune cells that normally migrate out of the vaginal epithelium into deeper tissues shortly after exposure to HIV-1.

The researchers found that HIV-1 simultaneously enters two different types of intraepithelial cells associated with the immune system, Langerhans cells (LC) and CD4+ T cells. However, the path of entry and rate of infection was different for the two cell types. Infection of CD4+ T cells appears to rely at least in part on expression of major HIV-1 coreceptors such as CCR5, whereas pathways for infection of vaginal LC appear to be more diverse and complex. In contrast to previous studies, infection of CD4+ T cells does not appear to require passage of the virus from LC.

Both LC and CD4+ T cells can migrate out of the vaginal epithelium. Study findings suggest that CD4+ T cells may be principally responsible for local shedding of the virus in the vagina of women infected with HIV-1 while LC may harbor viable virus for some time before spreading it to other cells.

These results reveal that it is necessary to consider mechanisms of viral entry into both CD4+ T and LC when searching for an effective way to interfere with infection through the vaginal epithelium.

"Our findings provide exciting definitive insights into the initial events of HIV-1 infection in the human vagina, which can guide the design of effective strategies to block local transmission and prevent HIV-1 spread," McElrath said.

The study was supported by NIH grants AI51980, HD51455 (F.H.), AI35605 (M.J.M.), and AI27757 (University of Washington CFAR); a Burroughs Wellcome Translational Research Award (M.J.M.); and the James B. Pendleton Trust (F.H. and M.J.M.). Publishing in Immunity, Vol. 26, Issue 2 February, 2007. http://www.immunity.com

McElrath is a member of the Clinical Research Division and the program in infectious diseases at the Hutchinson Center, as well as a professor of allergy and infectious diseases at the University of Washington School of Medicine. Hladik is an associate in clinical research at the Center and a research assistant professor of medicine and allergy and infectious diseases at the University of Washington School of Medicine.

At Fred Hutchinson Cancer Research Center, our interdisciplinary teams of world-renowned scientists and humanitarians work together to prevent, diagnose and treat cancer, HIV/AIDS and other diseases. Our researchers, including three Nobel laureates, bring a relentless pursuit and passion for health, knowledge and hope to their work and to the world. For more information, please visit fhcrc.org.

    CONTACT

    Dean Forbes

    (206) 667-2896

    

dforbes@fhcrc.org

Fred Hutchinson Cancer Research Center

CONTACT: Dean Forbes of Fred Hutchinson Cancer Research Center,+1-206-667-2896, dforbes@fhcrc.org

Web site: http://www.fhcrc.org/http:///

Terms and conditions of use apply
Copyright © 2007 PR Newswire Association LLC. All rights reserved.
A United Business Media Company

Posted: February 2007

View comments

Hide
(web3)